Orexigen Therapeutics Inc (NASDAQ:OREX)
| 5.25 Data as of Jan 30 |  -0.10 / -1.87%Today’s Change | 3.11 Today|||52-Week Range 7.82 | -13.37% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2010 | 2011 | 2012 | 2013 | |||
| Revenue and Income | Net Revenues | 1.2M | 4.4M | 3.4M | 3.4M | |
| Operating Expenses | Gross Income | -- | 4.0M | -- | -- | |
| Total Operating Expenses | 52.6M | 32.3M | 93.7M | 80.6M | ||
| Non-Operating Expenses | Operating Income | -51.4M | -27.9M | -90.2M | -77.2M | |
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -51.9M | -28.1M | -90.1M | -77.7M | |
| Net Income | -51.9M | -28.1M | -90.1M | -77.7M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 47.4M | 48.3M | 70.7M | 96.5M | |
| Shares To Calculate EPS Diluted | 47.4M | 48.3M | 70.7M | 96.5M | ||
| Earnings Per Share | EPS | -$1.10 | -$0.58 | -$1.27 | -$0.80 | |
| EPS Diluted | -- | -- | -- | -- | -- | |
.